Galena Biopharma Inc (GALE): Today's Featured Health Care Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Galena Biopharma ( GALE) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 2.0%. By the end of trading, Galena Biopharma fell $0.40 (-12.4%) to $2.82 on heavy volume. Throughout the day, 17,509,793 shares of Galena Biopharma exchanged hands as compared to its average daily volume of 8,967,000 shares. The stock ranged in price between $2.54-$3.02 after having opened the day at $2.63 as compared to the previous trading day's close of $3.22. Other companies within the Health Care sector that declined today were: Star Scientific ( STSI), down 10.7%, Oxygen Biotherapeutics ( OXBT), down 8.5%, Oncothyreon ( ONTY), down 8.1% and Natures Sunshine Products ( NATR), down 8.1%.

Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing oncology treatments to address major unmet medical needs to advance cancer care. It is developing a pipeline of immunotherapy product candidates for the treatment of various cancers based on the E75 peptide. Galena Biopharma has a market cap of $330.4 million and is part of the drugs industry. Shares are down 35.1% year to date as of the close of trading on Monday. Currently there are 8 analysts that rate Galena Biopharma a buy, 1 analyst rates it a sell, and none rate it a hold.

TheStreet Ratings rates Galena Biopharma as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, weak operating cash flow and feeble growth in its earnings per share.

On the positive front, Geron Corporation ( GERN), up 39.3%, BG Medicine ( BGMD), up 31.2%, Pernix Therapeutics Holdings ( PTX), up 19.9% and Oculus Innovative ( OCLS), up 18.7% , were all gainers within the health care sector with Pfizer ( PFE) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

More from Markets

NYSE Trader Expects Blowout Earnings From Alphabet, Amazon and Facebook

NYSE Trader Expects Blowout Earnings From Alphabet, Amazon and Facebook

Don't Panic! The Risk of a Recession This Year Is Low

Don't Panic! The Risk of a Recession This Year Is Low

Even Standing Desk Company Varidesk Is Watching How the Trump Tariffs Play Out

Even Standing Desk Company Varidesk Is Watching How the Trump Tariffs Play Out

State Street Gets Pummeled on Software Deal; Pizza Wars Are Raging -- ICYMI

State Street Gets Pummeled on Software Deal; Pizza Wars Are Raging -- ICYMI

Schlumberger Stock Dips as Investors Ignore Start of 'Earnings Liftoff'

Schlumberger Stock Dips as Investors Ignore Start of 'Earnings Liftoff'